VSEE HEALTH, INC. (VSEE) Form 424B3 — May 29, 2026
VSee Health filed a prospectus supplement to update information for the resale of up to 33.8 million shares by selling stockholders, including Manatt, Phelps & Phillips and Armistice. This filing signals significant potential selling pressure on the market, as these shares are registered for public resale. The attached 10-Q for the quarter ended March 31, 2026, reveals severe financial distress. The company reported a net loss of $2.6 million and an accumulated deficit of $85 million, with cash reserves of only $1.3 million against total liabilities of $12.7 million.
Key figures
- Revenue
- 3160185
- Total Debt
- 12695349
- Cash Position
- 1346132
- Shares Outstanding
- 48599421
- Total equity
- 6321070
- Last stock price
- 0.182
- Shares for resale
- 33808195
- Total liabilities
- 12695349
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.